Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Correction: Pharmacological Inhibition of MEK-ERK Signaling Enhances Th17 Differentiation

Andy Hee-Meng Tan and Kong-Peng Lam
J Immunol January 15, 2012, 188 (2) 924-925; DOI: https://doi.org/10.4049/jimmunol.1190085
Andy Hee-Meng Tan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kong-Peng Lam
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Tan, A. H.-M., and K.-P. Lam. 2010. Pharmacological inhibition of MEK–ERK signaling enhances Th17 differentiation. J. Immunol. 184: 1849–1857.

In Fig. 6B of our article, the wrong histological image corresponding to phase i of the “no cytokine group” was shown. The authors wish to replace the panel with the correct image. This replacement figure represents data obtained from the same experiment, and performed at the same time, as the rest of the data in the figure. The figure legend and main conclusions of the article remain unchanged.

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

ERK-inhibited Th17 cells precipitated early onset and more severe colitis. Th cells were cultured as in Fig. 2A. PBS or 5 × 105 in vitro differentiated cells were transferred i.p. into Rag–/– mice (PBS group, n = 5; no cytokine group, n = 5; no cytokine + U0126 group, n = 5; TGF-β + IL-6 group, n = 8; TGF-β + IL-6 + U0126, n = 7). The progression of wasting disease was monitored in terms of (A) change of body weights of mice expressed as a percent of their original weights and (B) degree of intestinal damage and leukocyte infiltration as assessed by histologic analysis of the distal colons of mice sacrificed 35–45 d (i) or 70–80 d (ii) after transfer. Features shown are representative sections from one mouse of three mice per treatment group (original magnification ×4). C, Th cells were isolated from mesenteric lymph nodes of mice that initially received untreated Th17 (TGF-β + IL-6) or ERK-inhibited Th17 (TGF-β + IL-6 + U0126) cells during phase i or ii. The cells were then seeded at 2 × 106/ml, stimulated with PMA and ionomycin in the presence of GolgiPlug Inhibitor for 6 h and assessed for their ex vivo expression of IL-17A and IFN-γ. D, Real-time RT-PCR to quantify the levels of il-22 transcript in Th cells isolated as in C. Data shown are representative of two independent experiments.

The corrected figure is below. The figure legend was correct as published and is shown below for reference. We regret any confusion and inconvenience this may have caused.

  • Copyright © 2012 by The American Association of Immunologists, Inc.

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606